FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Lumitron Get Breakthrough Status for New X-Ray

[ Price : $8.95]

FDA grants Lumitron Technologies a breakthrough device designation for its HyperVIEW X-Ray system for contrast-enhanced imaging fo...

RFK Jr.'s HHS Nomination Moves to Senate Floor

[ Price : $8.95]

HHS secretary-nominee Robert F. Kennedy Jr.s nomination moves one step closer to completion after the Senate Finance Committee vot...

Global Calcium CGMP Deviations

[ Price : $8.95]

FDA warns Indias Global Calcium about CGMP deviations in its manufacture of active pharmaceutical ingredients.

Susvimo OKd for Diabetic Macular Edema

[ Price : $8.95]

FDA approves a Genentech supplemental BLA for Susvimo (ranibizumab injection) 100 mg/mL for treating diabetic macular edema.

Gyder Hip System Cleared by FDA

[ Price : $8.95]

FDA clears a Gyder Surgical 510(k) for the Gyder Hip System and its use in positioning the acetabular cup during hip replacement s...

Medtronic Recalls Cerebrospinal Fluid Drain Device

[ Price : $8.95]

Medtronic Neurosurgery recalls certain Becker and Exacta External Drainage and Monitoring Systems due to a risk for cracks and lea...

2 Guides on Cell/Tissue Disease Transmission Delayed

[ Price : $8.95]

Federal Register notice: FDA delays by three months the effective dates of two final guidances on reducing the risk of transmissio...

Olympus Recalls Endoscope Accessory

[ Price : $8.95]

Olympus recalls its MAJ-891 endoscope accessory due to infection risks that may result from improper device reprocessing.

Lawyers Critique Guide on Unapproved Use Dissemination

[ Price : $8.95]

A Duane Morris client alert analyzes a recent FDA guidance on communicating scientific information to healthcare professionals abo...

Pfizer Seeks Braftovi Full Approval in Colon Cancer

[ Price : $8.95]

Pfizer seeks full approval for current accelerated-approved Braftovi (encorafenib) in combination with cetuximab (Erbitux) and mFO...